Research Site
Lørenskog N-1478
2 studies enrolling now · 11 studies all time
What they study most
Asthma, COPD (Chronic Obstructive Pulmonary Disease), Chronic Kidney Disease With High Proteinuria, Chronic Obstructive Pulmonary Disease (COPD), Eosinophilic Asthma, Eosinophilic Esophagitis, Metastatic Castration-resistant Prostate Cancer, Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis, Transthyretin Amyloid Cardiomyopathy, Unresectable Pleural Mesothelioma
Studies at this site
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease — Recruiting now
- Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment — Recruiting now
- Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis — Running, not enrolling
- MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma — Running, not enrolling
- Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO). — Completed
- Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria) — Running, not enrolling
- Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations — Completed
- Study of ALXN2220 Versus Placebo in Adults With ATTR-CM — Running, not enrolling
- A Study in Participants With Non-cirrhotic NASH With Fibrosis — Completed
- Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study) — Completed
- A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma. — Completed